Angany immunotherapy platform attracting attention from major players
Franco-Canadian start-up Angany claims to be “gaining momentum” for its plant-based immunotherapy platform. The firm aims to leverage the immunogenicity and safety profile of its plant-based eBioparticle technology for the development of therapeutic vaccines. Angany is working in both the human pharma and animal health sectors. It is targeting applications in allergy, autoimmune diseases, chronic […]
